Skip to main content

Table 2 Clinical characteristics and outcomes associated with TTP in 52 children with P. aeruginosa bacteremia

From: Prognostic role of time to positivity of blood culture in children with Pseudomonas aeruginosa bacteremia

Characteristics

Early TTP

(TTP ≤18 h, n = 21)

Late TTP

(TTP >18 h, n = 31)

P values

Basic information

 Age(years) (median, IQR)

0.85(0.48–8.79)

2.66(0.30–9.01)

0.911

 Male (n, %)

11(52.4%)

21(67.7%)

0.384

 Weight(kilogram)(median, IQR)

8.5(7.5–24.75)

13.5(6.00–28.00)

0.668

Underlying diseases

 Hematologic malignancies (n, %)

3(14.3%)

13(41.9%)

0.070

 Congenital heart disease (n, %)

3(14.3%)

3(9.7%)

0.946

Underlying conditions

 Immunosuppression (n, %)

6(28.6%)

20(64.5%)

0.023*

 Neutropenia (n, %)

10(47.6%)

14(45.2%)

1.000

 Hypoalbuminemia (n, %)

12(57.1%)

10(32.3%)

0.093

Complications

 Pneumonia (n, %)

4(19.0%)

5(16.1%)

1.000

 Meningitis (n, %)

3(14.3%)

2(6.5%)

0.645

 Peritonitis

2(9.5%)

1(3.2%)

0.727

Origins of infection

 Respiratory tract (n, %)

11(52.4%)

11(35.5%)

0.263

 Primary bacteremia (n, %)

2(9.5%)

5(16.1%)

0.787

 Vascular-catheter related infection (n, %)

3(14.3%)

5(16.7%)

1.000

 Soft tissue infection (n, %)

2(9.5%)

6(19.4%)

0.567

 Gastrointestinal infection (n, %)

3(14.3%)

2(6.5%)

0.645

 Post-surgery or-procedure bacteremia (n, %)

0(0.0%)

2(6.5%)

0.240

Intensive unit care (n, %)

13(61.9%)

7(22.6%)

0.008*

Nosocomial infection (n, %)

7(33.3%)

15(48.4%)

0.392

Pittsburgh bacteremia scores (median, IQR)

3.00(1.00–5.00)

1.00(1.00–4.00)

0.046*

Antibiotics administration before blood culture (n, %)

12(57.1%)

19(61.3%)

0.781

Length of hospitalization days (median, IQR)

21.04(2.82–41.29)

28.92(11.92–36.71)

0.176

Multi-drug resistance bacteria (n, %)

0(0.0%)

4(12.9%)

0.090

Outcomes

 Septic shock (n, %)

11(52.4%)

4(12.9%)

0.006*

 In-hospital mortality (n, %)

9(42.9%)

3(9.7%)

0.014*

  1. * Indicates statistical significant results, P<0.05